Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

Mina Aziz, Jay Shah, Urvi Kapoor, Christina Dimopoulos, Sarah Anand, Allan Augustine, Francis Ayuk, Mohammed S. Chaudhry, Yi‐Bin Chen, Hannah Choe, Aaron Etra, Stephanie Gergoudis, Matthew J. Hartwell, Elizabeth O. Hexner, William J. Hogan, Carrie L. Kitko, Steven Kowalyk, Nicolaus Kröger, Pietro Merli, George Morales, Ryotaro Nakamura, Rainer Ordemann, Michael A. Pulsipher, Muna Qayed, Ran Reshef, Wolf Rösler, Tal Schechter, Elisabeth Schreiner, Hrishikesh K. Srinagesh, Matthias Wölfl, Kitsada Wudhikarn, Gregory A. Yanik, Rachel Young, Umut Özbek, James L.M. Ferrara, John E. Levine